Fundraising FoxNarya Capital — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Chapter provides lead intelligence for B2B software companies by scanning the internet in real-time to identify relevant prospects based on immediacy and buying intent, serving developer tool vendors seeking high-quality sales outreach.
AI & Machine LearningFintechInsurTechSaaSSales TechSeattle, US
Aditya (JP) Jayaprakash(Co-Founder & CEO)Ece Kayan(Cofounder)
Co-investorsRubio Impact VenturesTechstars8VCAdditionCore Innovation CapitalFifth Down Capital+6 more
Reprogram Biosciences develops an in vivo immunotherapy that uses a therapeutic gene cocktail delivered via lipid nanoparticles to reprogram solid-tumor cancer cells into immune-like cells.
AI & Machine LearningBiotechDeep TechSan Carlos, US
Rustam Esanov(Co-founder & CEO)inEziz Kuliyev(Co-founder & COO)inAngela Yang(Head of Research)inAnnageldi Tayyrov(Head of AI Platform)in
Co-investorsUnshackled Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.